Collectively, these results outlined a critical role for ATF2 overexpression; that is, to reverse the ability of PDIA3 knockdown to ameliorate ox-LDL-induced endothelial dysfunction in HUVECs. The gene discussed is ATF2; the disease is endothelial dysfunction.